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ABSTRACT 
 
Human papillomavirus type 11 (HPV-11) infects the genital and the respiratory tract leading to 
condylomas and respiratory papillomatosis. HPV infections are restricted to epithelial tissue and 
the progression through the virus lifecycle is tightly coordinated to the differentiation of the host 
cell. The changes of cellular microRNAs by HPV-11 gene expression were investigated in a cell 
culture model of HaCaT cells transfected with HPV-11, with the goal of understanding which 
cellular processes were affected by the virus.  Human microRNA profiling was conducted on three 
different array platform systems and because very few microRNAs (miR-663, -638, -149* and -
92b*) were consistently found in all three array data sets we performed extensive statistical 
analyses of the array data and the qRT-PCR validation. We assume that the most reliable 
differentially expressed microRNAs are the ones identified by more than one array platform. We 
also show that TaqMan® qRT-PCR validation is of limited use for less abundant microRNAs.  
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INTRODUCTION 
 
HPV plays an important role in the development of both malignant and benign diseases of which 
genital condylomas, oral- and laryngeal papillomas are the most prevalent. These highly 
proliferative infections are most often caused by HPV-11 but when developed into malignant 
lesions the most prevalent HPV type is HPV-16 sometimes combined with HPV-11 [1-3]. The HPV 
life-cycle is tightly coordinated to the differentiation program of the epithelium and the primary 
infection occurs in the basal and parabasal cell layers of the squamous- or mucous epithelium. 
Replication of the viral genome and transcription takes place in more differentiated cells in the mid- 
or upper spinous cells. The genome encodes seven early proteins and two late structural proteins 
which form the viral capsids. The viral proteins E6 and E7 are involved in cell cycle deregulation 
and prevention of apoptosis whereas the E1 and E2 proteins are of importance for genome 
replication. The two E5 proteins E5a and E5b influence the signal transduction pathways and 
therefore contribute to the deregulation of cell growth [2;4]. The virus particles are assembled in 
fully differentiated cells and infectious virus particles are released from the surface of the tissue [4]. 
It is hypothesized that regulation of viral progression during the normal life cycle and the tight 
cooperation with the differentiation of the host cell is driven by changes in cellular microRNAs 
(miRNAs) [5;6]. MiRNAs regulate gene expression through binding to the 5’- or 3’-noncoding 
regions of mRNAs and hereby translation of proteins is inhibited [7;8]. Several miRNAs are known 
to regulate cell differentiation of stem cells [9-11] as well as being differentially expressed in tumor 
cells and tissue [12-15]. 
To understand if cellular miRNAs influence HPV-11 gene expression - and because no HPV-11 
positive cell lines are available - we developed a model system where the full genome of HPV-11 
was transfected into the HPV negative human keratinocyte cell line, HaCaT, together with a 
neomycin resistance marker. RNA was isolated from selected cells containing HPV-11 and control 
cells, respectively and subsequently analyzed by microarray analysis. In order to obtain robust 
information we used three commercial array platforms for the analysis. A large number of 
differentially expressed miRNAs was found in all three platforms after applying stringent statistics. 
However, each array platform detected a different subset of differentially expressed miRNAs with 
only a small overlap between platforms. A recent study conducted by Git et al observed similar 
discrepancies [16].  
In the present study we discuss the changes in miRNA expression derived by HPV-11 transfection. 
We focus on miRNAs shared by more than one array platform (Invitrogen, Exiqon and Affymetrix) 
and analyze the agreement between the expression values derived from either microarrays or 
quantitative reverse transcription PCR (qRT-PCR). 
MATERIALS & METHODS 
 
Cell culture and stable transfections  
The HPV-negative human keratinocyte cell line HaCaT, originally established from a human skin 
biopsy, was cultivated in Dulbecco’s Modified Eagle Medium (DMEM 1965, Invitrogen) 
supplemented with 10% Fetal Bovine Serum, 1% Penicillin/Streptomycin, 1% L-glutamate and 1% 
of 0.1M sodium pyruvate. Cells were grown under standard conditions at 37°C and 5% CO2 and all 
experiments were done in triplicates. Cells were either transfected with 6 µg of circularized full 
genome HPV-11 DNA and 2 µg of selection vector pSV2-neo or with only 2 µg of pSV2-neo. 
Transfections were done using jetPEITM transfection reagent (Polyplus Transfections) following 
manufacturer’s instructions. The neomycin resistant cells were maintained by adding 500 µg per ml 
G418 sulfate (Invitrogen) to the growth medium 24 hours post-transfection. In order to standardize, 
cells were stringently transfected and harvested in the same passage. 
 
DNA/RNA extraction 
Transfected cells were grown with and without antibiotic selection and HPV-11 and pSV2-neo 
transfected dishes were harvested at three time points (48 hours, 2 weeks and 3 weeks). DNA was 
purified using the Invisorb Spin Tissue Mini Kit (Invetek) according to manufacturer’s instructions. 
Triplicate of transfected cells were harvested at ~80% confluence and totalRNA was extracted 
using TriZOL reagent (Invitrogen) following the manufacturer’s protocol. 
 
HPV-11 DNA quantitation by PCR 
250 ng of DNA were amplified by PCR using primers for HPV-11 non-coding region (NCR) 
resulting in a fragment of 755 nucleotides. GAPDH was used as an internal control. The primers 
used were the following: NCR: Forward primer 5’- TACGTACCCGGGTATATGTGTGTCAGTGTG 
and the reverse primer 5’ - TATGCTAAGCTTACTTTCCATAATGCCTCG. The GAPDH forward 
primer was 5’ - TGCACCACCAACTGCTTAG and the reverse primer 5’- 
GATGCAGGGATGATGTTC. The PCR program held an annealing temperature of 60°C for HPV-
11 and 50°C for GAPDH and was initiated upon 15 min. at 95°C, followed by 35 repeated cycles (1 
min.95°C, 1 min.60°C/ or 50°C, 2 min.72°C), ending with 10 min. at 72°C.   
 
RNA labeling, hybridization and microarray platforms  
Affymetrix platform: In a one-color labeling system, 1000 ng of totalRNA was labeled using 
FlashTag™ Biotin RNA Labeling Kits from Genishere and hybridized to Affymetrix GeneChip® 
miRNA Array according to manufacturer’s instructions. Affymetrix miRNA-array contains probes for 
847 human miRNAs; all cataloged in the miRBase Sequence Database (Release 11.0, 
http://microrna.sanger.ac.uk/).  
Exiqon platform: In a two-color labeling system, 1000 ng of totalRNA was labeled with fluorescent 
Hy3™(sample)/Hy5™(reference-sample) dye from the miRCURY LNA™microRNA Array Power 
Labeling Kit (Exiqon, Vedbaek, Denmark) according to manufacturer’s instructions. Using a 
TECAN hybridization station, labeled samples were hybridized overnight to pre-printed miRCURY 
LNA™ microRNA Array, v.11.0 (Exiqon), containing probes for 841 human miRNAs, cataloged in 
the miRBase Sequence Database. Arrays were scanned in an Agilent DNA Microarray Scanner, 
(Agilent Technologies, Santa Clara, CA) and resulting images analyzed with Genepix Pro 6.0 
software (Molecular Devices, Sunnyvale, CA). 
Invitrogen platform: Also in a two-color labeling system, miRNA expression levels were determined 
by microarray analysis. Around 2000 ng of totalRNA was labeled with fluorescent Alexa Fluor dyes 
using the NCode¥ Rapid miRNA Labeling System (Invitrogen). The samples were labeled with 
Cy5 and a mirVana™ miRNA Reference Panel v9.1 (Ambion) with Cy3, and hybridized overnight 
in a TECAN hybridization station to NCode¥Human miRNA Microarrays V3 (Invitrogen), which 
contains probes corresponding to 710 miRNAs, cataloged in the miRBase Sequence Database, 
Release 10.0. Arrays were subsequently handled as described for the Exiqon platform. 
  
Microarray data pre-processing 
Affymetrix: Microarray data generated by Affymetrix miRNA Array v1.0 platform were normalized 
by means of miRNA QCTool version 1.0.33.0, available from affymetrix.com. Default parameters 
were used. Normalized expression values (log2, single channel intensities) were exported into R 
environment [17] for subsequent analysis. The data set contained 847 probes and was filtered to 
exclude probes showing little or no variance (standard deviation < 0.2). The filtered data set 
contained 488 probes.  
Exiqon and Invitrogen: The importing and pre-processing of the Exiqon and Invitrogen data were 
performed using LIMMA package [18] of Bioconductor project [19]. 
Data from each platform was processed separately. The mean spot pixel intensities were taken to 
estimate the foreground and median intensities of surrounding pixels were used for local 
background estimation. Spots with a quality Flags-value less than -99 were excluded from the 
analysis. The “normexp”, plus offset=50 method [20] was used for background correction. 
Subsequently, the log2 Green/Red ratios were computed and normalized by LOESS normalization 
[21]. Finally, log2 ratios of intra-slide replicate spots were averaged. There were three intra-slide 
replicate spots for each probe in Invitrogen and four in Exiqon. The Exiqon data sets contained 834 
probes and after filtering to exclude probes showing standard deviation below 0.15, the data set 
was reduced to 381 probes. The Invitrogen data set of 705 probes was filtered using standard 
deviation threshold of 0.05 resulting in 304 probes in the final data set. 
          
Statistical analysis 
The differentially expressed miRNAs were identified by means of empirical Bayes moderated t-
statistics as implemented in LIMMA [18]. The p-values were adjusted for multiple testing by 
Benjamini and Hochberg False Discovery Rate method and significance level of 0.05 was used for 
statistical testing. 
 
Reverse transcription PCR  
CDNA was prepared from 100 ng totalRNA from cultured cells using TaqMan®  MicroRNA Reverse 
Transcription Kit and TaqMan®  MicroRNA Assays containing predesigned primers were added. 
MiR-191, RNU6B, and RNU48 were used for endogenous control [22;23]. RT-PCR reaction was 
performed using TaqMan® Universal PCR Master Mix No AmpEras® UNG, according to 
manufacturer’s instructions, all from Applied Biosystems. Each amplification reaction was 
performed in triplicates and median value of the three cycle threshold was used for further 
analysis. For calculations of fold changes we used the 2-∆CT method [24].  
 
RESULTS 
 
Cell cultures 
The HPV negative keratinocyte cell line HaCaT was selected in order to study the HPV mediated 
changes in the miRNA profile under controlled growth conditions. This made it possible to extract 
RNA from HPV-11 and control transfected cells grown in parallel and to analyze the differentially 
expressed miRNA as a result of HPV-11 gene expression. HPV DNA replication is not expected 
and subsequent analysis of HPV-11 DNA maintenance was necessary. The amount of HPV-11 
DNA per µg of total DNA decreased with time but HPV-11 was still abundant after three weeks of 
selection emphasizing that the cell cultures maintain the HPV-11 genome, hereby verifying that the 
model mimics infected cells. Furthermore, the transcription of the viral genomes was active as 
demonstrated by the presence of HPV-11 E7 mRNA (data not shown). 
 
Differentially expressed miRNAs 
Expression of cellular miRNAs in HPV-11 transfected HaCaT cells was measured on three 
different array platforms developed by Invitrogen, Exiqon, and Affymetrix, for latter platform, see 
Figure 1 for Heatmap of differentially expressed miRNAs. We compared the lists of differentially 
expressed miRNAs from each platform to determine the agreement between microarray platforms. 
A total of 33 miRNAs were differentially expressed by the Invitrogen-, 50 by the Affymetrix-, and 92 
by the Exiqon platform with a significance level of p<0.05. P-values were adjusted for multiple 
testing by Benjamini & Hochberg method. Surprisingly, there were few differentially expressed 
miRNAs in common between the three platforms and only four miRNAs (miR-149*, -638, -663, and 
-92b*) were confirmed on all platforms. Additionally there were 10 miRNAs differentially expressed 
on two out of three platforms. Only one miRNA was shared between the Invitrogen and the 
Affymetrix platforms, five miRNAs were shared between the Invitrogen and the Exiqon platforms, 
and four miRNAs between the Affymetrix and the Exiqon platforms, see Figure 2 for Venn diagram. 
Lists of differentially expressed miRNAs for each microarray platform are available in 
supplementary Tables S1A, -1B, and -1C. 
 
Validation of differentially expressed miRNAs by qRT-PCR 
Fold Changes (FC) of differentially expressed miRNAs ranged from +3.3 to -10.3. Comparison of 
FC values derived from the different platforms correlated with only one exception – FC of miR-584 
showed downregulation in Invitrogen and upregulation in Exiqon (Table 1). MiRNAs which showed 
differential expression on at least two platforms were validated by qRT-PCR. All qRT-PCR analysis 
was done relative to three internal controls, RNU6b, RNU48 and miR-191. Results showed 
variation according to choice of internal control, where the most consistent findings were obtained 
for miR-149*, -7, -1228*, and -886-3p. For the latter miRNAs up- or downregulation did not vary 
according to internal controls (Table 1). MiR-663 and miR-608 were not validated, as no 
commercial primers for the TaqMan® system were available and introducing an additional design of 
primers did not seem favorable with respect to comparability. MiR-654-5p and -185* gave poor 
results with cycling-threshold (CT) above 39 by qRT-PCR although they obtained high array 
intensities and were differentially expressed (supplementary material Table S-1B).  
In addition to the miRNAs analyzed by qRT-PCR and listed in Table 1, a few miRNAs were 
selected among the miRNAs differentially expressed in only one of the data sets from either 
Invitrogen, Affymetrix or Exiqon platform, respectively. These unique miRNAs were selected 
among the miRNAs expressed in relatively low- (< 4), intermediate- (5-6), or high- (> 6) level 
according to array intensities. The qRT-PCR data showed relatively low FC for the selected 
miRNAs and results are only shown with miR-191 as reference, since these results showed the 
highest correlation with array based FC (Tables S-1A, -1B, -1C).  It was only possible to obtain 
consistent CT values for miRNAs with high array intensities and thus qRT-PCR results for miRNAs 
with intermediate or low array intensities were not viable. Because of the discrepancy between the 
array FC values and the qRT-PCR results we conducted a more in depth correlation analysis as 
described below. 
 Correlations between microarray results and qRT-PCR validation  
For the 9 miRNAs shown to be differentially expressed by at least 2 array platforms and where 
qRT-PCR results were obtained, we calculated Pearson correlation coefficient (R) to assess the 
agreement between expression values generated by the different methods used. We compared the 
correlations a) between three array platforms, b) between CT values and internal controls, and c) 
between array intensities and CT values (Table 2). Based on Table 2, the results show higher 
correlations between the different array platforms than between different internal controls in qRT-
PCR – analysis. It is evident that there is only little or no correlation between array and qRT-PCR 
data. Only miR-886-3p shows high correlation both between the three different internal controls in 
qRT-PCR, between Exiqon and Affymetrix, and between array platforms and qRT-PCR. Even 
when correlating with Invitrogen results, which gave the poorest correlations of miR-886-3p (R = 
0.50-0.78) we still found acceptable correlations.  
 
DISCUSSION 
 
MiRNA profiling of HPV-11 transfected HaCaT cells on three different array platforms showed very 
few differentially expressed miRNAs in common between all three data sets. We performed an 
extensive validation and statistical analyses of the data, hereby revealing discrepancies of results 
based on the different internal controls when analyzing with qRT-PCR (Table 1). The disagreement 
between internal controls presents a general problem as the true expression of miRNAs is 
unknown and therefore reliability of the qRT-PCR results has to be questioned. Is qRT-PCR 
analysis the best method of validating array data since internal controls are not always consistently 
expressed? We observed cases where two internal controls derived opposite results (Table 1), and 
this might lead to unsupported conclusions.  
QRT-PCR validation does not confirm miRNAs with a low FC based on array data although 
validated miRNAs are in agreement with more than one array platform. MiRNAs with a FC <2 tend 
to have random signature in qRT-PCR validation and disagreeing with direction of changes. QRT-
PCR validation of miR-886-3p was in agreement with array data and internal controls, all with FC 
<2. However, microarray derived data confirm numeric values of differential expressed miRNAs 
(see Tables 2) also in cases where FC were relatively low (~2.5). This result is consistent with the 
fold changes described before, where miR-886-3p was shown to be downregulated upon HPV-11 
transfection by Exiqon and Affymetrix platforms and when using all qRT-PCR internal controls. 
MiR-886-3p shows a FC of -10 (Affymetrix), which is the highest numeric FC observed. This 
suggests that greater miRNA alterations are easier confirmed by other methods. The problem 
occurs when only subtle alterations need to be confirmed. 
Our results conclude that microarrays are more sensitive and reproducible than TaqMan® qRT-
PCR when changes in miRNA expression are small.  The results are restricted to a subset of 
miRNAs which were chosen based on array result, so more comprehensive selection of miRNAs 
should be used to draw a more global conclusion. The fact that qRT-PCR may be superior to array 
technologies for mRNA profiling in terms of specificity and sensitivity does not mean that this is 
also true for miRNAs. The short length of miRNAs (~21nt) may present problems for probe design 
as well as consistent expression of internal controls.  
Furthermore we show that reliable and reproducible results can be obtained combining power of 
two or more microarray platforms, especially when miRNA expressions can only be partially 
confirmed by qRT-PCR. In our settings, results obtained from a combination of two platforms would 
be better validated by a third platform than by qRT-PCRs, e.g. four of five miRNAs differentially 
expressed by the combination of Invitrogen and Affymetrix would be confirmed by Exiqon array 
analysis (Fig.2). Half of the miRNAs differentially expressed by the combination of Exiqon and 
Affymetrix were confirmed by Invitrogen array analysis which was also the case for miRNAs shared 
between Exiqon and Invitrogen and confirmed by Affymetrix array.  
 
In conclusion, our analysis identified 14 miRNAs which showed differential expression on more 
than one array platform and miR-886-3p was additionally confirmed by qRT-PCR profiling. We 
believe that these 14 miRNAs are truly altered by HPV-11 transfection and consequently these 
miRNAs are being further analyzed to reveal their involvement in HPV-11 induced cellular 
response.    
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Table 1: Significantly changed miRNAs shared between two or more platforms. Fold Change 
derived from array platforms and qRT-PCR validation with different miRNAs used as internal 
control (RNU6B, RNU48, miR-191) are shown. *nd = not done, **nv = not valid. 
 
Table 2: Correlations between array intensities and qRT-PCR derived cycling threshold 
(CT). The table depicts Pearson correlations coefficient (R) between a) array platforms, b) CT 
values and internal controls, and c) array intensities and CT values for the 9 miRNAs shared 
between two or more platforms and validated by qRT-PCR. Highlighted values indicate R > 0.80 
which reflects acceptable correlation. 
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List of Figures 
 
Figure 1: Heatmap showing the expression levels of 14 miRNA shown to be differentially 
expressed by at least 2 microarray platforms. The rows of the heatmap (miRNAs) were 
reordered according to hierarchical clustering. Relatively low expression levels are presented as 
dark red and relatively high expression levels are presented as bright yellow. The expressions 
levels from Affymetrix platform were used. In general, a clear pattern of differential expression is 
visible for the miRNAs selected by Affymetrix platform. 3 out of 5 miRNAs selected by Exiqon and 
Invitrogen only (marked by "E/I") show smaller difference between pSV2−neo and HPV-11 
transfected cells, which was apparently not enough to be picked by statistical testing. The 
remaining 2 miRNAs, namely miR-608 and miR-654-5p do not seem to be differentially expressed 
according to Affymetrix data even though they were selected by Exiqon and Invitrogen platforms. 
 
Figure 2: Venn diagram showing the overlap of the platforms. Lists of differentially expressed 
miRNAs (p < 0.05) were compared and the agreement between the microarray platforms is 
depicted. The shared miRNAs are listed in Table 1. 
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Shared plarforms ID
Invitrogen Exiqon Affymetrix RNU6B RNU48 miR-191
miR-663 1.7 1.8 2.5 nd* nd* nd*
miR-638 1.6 2.6 2.6 -1.2 -1.3 1.2
miR-149* 1.2 1.3 2.6 -1.6 -1.6 -1.1
miR-92b* 1.2 1.3 2.4 -1.8 -1.3 1.1
miR-654-5p 1.4 1.8 nv** nv** nv**
miR-608 1.2 1.5 nd* nd* nd*
miR-584 -1.2 2.6 1.7 -1.2 -1.3
miR-185* 1.2 1.4 nv** nv** nv**
miR-7 -1.5 -1.9 -1.3 -1.1 -1.1
miR-1228* 1.4 2.7 1.1 1.2 1.8
miR-886-3p -2.2 -10.3 -2.7 -7.3 -2.1
miR-874 2.0 1.9 nv** nv** nv**
miR-720 -1.4 -1.8 -1.1 1.1 1.7
Affymetrix/ 
Exiqon
miR-125a-5p 1.2 3.3 -1.4 -1.1 1.3
Fold Change microarray Fold Change qRT-PCR
Affymetrix/ 
Exiqon/ 
Invitrogen
Exiqon/ 
Invitrogen
Invitrogen/ 
Affymetrix
Table 1
Invitrogen/ 
Affymetrix
miR-638 miR-149* miR-92b* miR-584 miR-7 miR-125a-5p miR-1228* miR-886-3p miR-720
Exiqon/Affymetrix 0.99 0.89 0.84 -0.85 0.82 0.33 0.77 0.96 0.72
Exiqon/Invitrogen 0.98 0.83 0.93 -0.65 0.99 0.77 NA 0.70 NA
Affymetrix/Invitrogen 0.98 0.95 0.91 0.51 0.81 0.72 NA 0.50 NA
RNU6B 0.74 0.71 0.39 0.91 0.84 0.00 0.95 0.91 0.87
RNU48 0.40 0.47 0.51 0.69 0.79 -0.78 0.66 0.97 0.33
miR-191 0.51 0.60 0.67 0.88 0.58 -0.52 0.64 0.97 0.19
Exiqon/RNU6B -0.17 -0.44 -0.16 0.06 0.48 0.22 0.31 0.95 0.18
Exiqon/RNU48 -0.54 -0.79 -0.53 -0.17 0.53 -0.21 0.02 0.97 0.25
Exiqon/miR-191 0.02 -0.39 0.22 -0.28 0.53 -0.03 0.29 0.94 -0.19
Affymetrix/RNU6B -0.19 -0.52 -0.35 0.35 0.32 -0.11 0.02 0.87 -0.43
Affymetrix/RNU48 -0.52 -0.84 -0.82 0.65 0.83 -0.68 -0.03 0.93 0.04
Affymetrix/miR-191 0.05 -0.39 0.13 0.71 0.64 0.68 0.22 0.82 -0.43
Invitrogen/RNU6B -0.17 -0.75 -0.36 0.19 0.44 -0.19 NA 0.78 NA
Invitrogen/RNU48 -0.48 -0.87 -0.77 0.13 0.48 -0.27 NA 0.66 NA
Invitrogen/miR-191 -0.02 -0.49 -0.01 0.26 0.49 0.50 NA 0.78 NA
b) Correlations between CT values and internal controls
c) Correlations between array intensities and CT values
Affymetrix/Exiqon/Invitrogen Exiqon/Invitrogen Affymetrix/Exiqon
a) Correlations between array platforms
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